ImmuCell Corporation (ICCC): $9.73

-0.02 (-0.26%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ICCC to Watchlist
Sign Up

Industry: Biotech


Ranked

of 481

in industry

Immucell Corp (ICCC) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Immucell Corp.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
1 $14 $14 $14 $9.9 41.41%

Price Target Last Issued April 1, 2021

The Trend in the Analyst Price Target


list("500 - Internal server error")

ICCC reports an average of 82.82% for its upside potential over the past 253 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-07-10 1 14 14 14 5.553 152.12%
2020-12-07 1 14 14 14 5.990 133.72%
2020-12-09 1 14 14 14 6.060 131.02%
2020-12-19 1 14 14 14 6.230 124.72%
2020-12-26 1 14 14 14 6.250 124%
2021-01-02 1 14 14 14 5.950 135.29%
2021-01-09 1 14 14 14 6.230 124.72%
2021-01-16 1 14 14 14 6.260 123.64%
2021-01-23 1 14 14 14 7.250 93.1%
2021-01-30 1 14 14 14 9.350 49.73%
2021-02-06 1 14 14 14 11.020 27.04%
2021-02-13 1 14 14 14 10.920 28.21%
2021-02-20 1 14 14 14 11.880 17.85%
2021-02-27 1 14 14 14 10.520 33.08%
2021-03-06 1 14 14 14 9.080 54.19%
2021-03-13 1 14 14 14 10.770 29.99%
2021-03-20 1 14 14 14 11.160 25.45%

ICCC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 0 1 0 0 0 1

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The number of analysts covering the stock of ICCC is higher than practically none of all US stocks.
  • Immucell Corp's variance in analysts' estimates is lower than almost 100% of all US stocks.
  • The upside potential (average analyst target price relative to current price) of ICCC is higher than 75.12% of all US stocks.
  • ICCC has a greater average analyst price target than 28.55% of all US stocks.

Stocks similar to Immucell Corp in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PHIO, IPA and GNPX.

Is ICCC a Buy, Hold or Sell? See the POWR Ratings now!



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.836 seconds.